Skip to Content

GMO Benchmark-Free Allocation IV GBMBX Fund Analysis

| Medalist Rating as of | See GMO Investment Hub

Morningstar’s Analysis GBMBX

Will GBMBX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A consistently contrarian approach that requires patience.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark-Free Allocation packages the firm’s contrarian views and value-driven asset-class forecasts. The differentiated approach is consistently applied by a research-focused team, but it can face prolonged periods of underperformance.

Rated on Published on

Unlock our full analysis with Morningstar Investor